Clinical Trial: Long-term Extension Study of Ligelizumab in Food Allergy
Study Status: Completed
Recruit Status: RECRUITING
Condition: Food Allergy
Study Type: INTERVENTIONAL
Official Title: A Three-year, Multi-center, Double-blind, Extension Study to Evaluate the Long-term Safety and Efficacy of Ligelizumab in Patients Who Completed Ligelizumab's Phase III Studies in Food Allergy
Brief Summary:
This is an extension study to evaluate the long-term safety and efficacy of ligelizumab in particiants who have completed a ligelizumab Phase III study in food allergy.
Read more